Clincosm LogoSign in Get a demo

stage ia breast cancer ajcc v7

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2/Neu Positive, Progesterone Receptor Positive, Recurrent Breast Carcinoma Trial in Worldwide (drug, other, biological)

Active, not recruiting
Has Results
  • HER2/Neu Positive
  • +8 more
  • Anniston, Alabama
  • +1291 more
Jan 28, 2023

Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7 Trial in Worldwide (drug, other, radiation)

Active, not recruiting
Has Results
  • Breast Adenocarcinoma
  • +6 more
  • Anniston, Alabama
  • +1230 more
Jan 28, 2023

Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7 Trial in Scottsdale, Jacksonville,

Active, not recruiting
  • Stage I Breast Cancer AJCC v7
  • +6 more
  • Hypofractionated Radiation Therapy
  • +2 more
  • Scottsdale, Arizona
  • +2 more
Jan 3, 2023

Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in United States

Recruiting
  • Stage 0 Breast Cancer AJCC v6 and v7
  • +10 more
  • Telemedicine
  • +6 more
  • Washington Township, New Jersey
  • +4 more
Oct 18, 2022

Peripheral Neuropathy, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Columbus (Educational

Completed
  • Peripheral Neuropathy
  • +6 more
  • Educational Intervention
  • +4 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Oct 10, 2022

Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in United States

Recruiting
  • Invasive Breast Carcinoma
  • +8 more
  • Hypofractionated Radiation Therapy
  • +4 more
  • Gilbert, Arizona
  • +8 more
Jun 23, 2022

Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Detroit (Laboratory Biomarker

Active, not recruiting
  • Invasive Breast Carcinoma
  • +6 more
  • Detroit, Michigan
    Wayne State University/Karmanos Cancer Institute
Jun 17, 2022

Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in United States (drug, other,

Recruiting
  • Invasive Breast Carcinoma
  • +11 more
  • Conroe, Texas
  • +4 more
May 3, 2022

Positive Axillary Lymph Node, Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7 Trial in Los Angeles

Completed
  • Positive Axillary Lymph Node
  • +11 more
  • Implanted Medical Device
  • Therapeutic Conventional Surgery
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Mar 29, 2022

Cancer Survivor, Stage I Breast Cancer AJCC v7, Stage I Colon Cancer AJCC v6 and v7 Trial in Scottsdale (American Ginseng,

Completed
  • Cancer Survivor
  • +19 more
  • American Ginseng
  • +3 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Mar 22, 2022

Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Houston (procedure, drug,

Recruiting
  • Invasive Breast Carcinoma
  • +11 more
  • Axillary Lymph Node Dissection
  • +5 more
  • Houston, Texas
  • +1 more
Mar 10, 2022

Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In Situ, Stage 0 Breast Cancer AJCC v6 and v7 Trial in Los Angeles,

Active, not recruiting
  • Breast Ductal Carcinoma In Situ
  • +12 more
  • Endoxifen Hydrochloride
  • +2 more
  • Los Angeles, California
  • +2 more
Mar 8, 2022

Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7 Trial in Houston (Carboplatin,

Recruiting
  • Stage I Breast Cancer AJCC v7
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 12, 2022

Breast Adenocarcinoma, Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma Trial in Houston (Accelerated Partial Breast

Recruiting
  • Breast Adenocarcinoma
  • +9 more
  • Accelerated Partial Breast Irradiation
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 21, 2021

Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Italy, United

Active, not recruiting
  • Stage 0 Breast Cancer AJCC v6 and v7
  • +6 more
  • Tampa, Florida
  • +4 more
Dec 15, 2021

Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v6 Trial in United States (External Beam

Active, not recruiting
Has Results
  • Ductal Breast Carcinoma In Situ
  • +7 more
  • External Beam Radiation Therapy
  • +5 more
  • Gilbert, Arizona
  • +6 more
Oct 21, 2021

Ductal Breast Carcinoma In Situ, Early-Stage Breast Carcinoma, Invasive Breast Carcinoma Trial in United States (Laboratory

Recruiting
  • Ductal Breast Carcinoma In Situ
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Jacksonville, Florida
  • +15 more
Oct 12, 2021

HER2 Positive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Norfolk, Omaha (drug,

Active, not recruiting
  • HER2 Positive Breast Carcinoma
  • +6 more
  • Norfolk, Nebraska
  • +2 more
Sep 1, 2021

Estrogen Receptor Negative, HER2 Positive Breast Carcinoma, HER2/Neu Negative Trial in United States (External Beam Radiation

Recruiting
  • Estrogen Receptor Negative
  • +11 more
  • External Beam Radiation Therapy
  • +4 more
  • Phoenix, Arizona
  • +7 more
Aug 4, 2021

Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7 Trial in Houston

Recruiting
  • Stage I Breast Cancer AJCC v7
  • +9 more
  • Electroacupuncture Therapy
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2021

Breast Adenocarcinoma, HER2 Positive Breast Carcinoma, Stage IA Breast Cancer AJCC v7 Trial in Worldwide (drug, other,

Completed
  • Breast Adenocarcinoma
  • +6 more
  • Aromatase Inhibition Therapy
  • +6 more
  • Birmingham, Alabama
  • +156 more
Aug 13, 2020

Cancer Survivor, Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7 Trial in Los Angeles, Riverside (Behavioral

Completed
  • Cancer Survivor
  • +8 more
  • Behavioral Intervention
  • Questionnaire Administration
  • Los Angeles, California
  • +1 more
Jul 22, 2020